Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 54.85 Million USD | 44.83% |
| 2021 | 37.87 Million USD | 7800.27% |
| 2020 | -491.82 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 53.96 Million USD | -6.57% |
| 2023 Q1 | 57.76 Million USD | 5.31% |
| 2022 FY | 54.85 Million USD | 44.83% |
| 2022 Q4 | 54.85 Million USD | 63.04% |
| 2022 Q1 | 3.89 Million USD | -89.71% |
| 2022 Q2 | 9.62 Million USD | 147.0% |
| 2022 Q3 | 33.64 Million USD | 249.61% |
| 2021 Q1 | -947.9 Thousand USD | -92.73% |
| 2021 FY | 37.87 Million USD | 7800.27% |
| 2021 Q4 | 37.87 Million USD | 12519.33% |
| 2021 Q3 | -304.94 Thousand USD | 61.48% |
| 2021 Q2 | -791.6 Thousand USD | 16.49% |
| 2020 Q4 | -491.82 Thousand USD | 0.0% |
| 2020 FY | -491.82 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 4187199.237% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -871.094% |
| Evofem Biosciences, Inc. | 42.79 Million USD | -28.178% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 22073.8% |
| Rebus Holdings, Inc. | 305 Thousand USD | -17883.934% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 970.026% |
| Qrons Inc. | 351.42 Thousand USD | -15508.078% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -8713.331% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | -26.286% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 268872.05% |
| Skye Bioscience, Inc. | -5.72 Million USD | 1058.701% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | -247.973% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -1231.974% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -13549.654% |
| SQZ Biotechnologies Company | -36.23 Million USD | 251.363% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -2346.267% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -5815.857% |
| Mesoblast Limited | 55.85 Million USD | 1.803% |
| Marizyme, Inc. | 18.56 Million USD | -195.39% |
| Genus plc | 190.6 Million USD | 71.222% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -2353.27% |
| Pharming Group N.V. | 109.8 Million USD | 50.046% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -6276.236% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -4418.621% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -7966.324% |
| ContraFect Corporation | -6.02 Million USD | 1010.239% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -40639.31% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -4647.241% |
| IMV Inc. | 7.67 Million USD | -615.088% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -896.947% |
| MultiCell Technologies, Inc. | 90.04 USD | -60918380.675% |
| ONE Bio Corp. | 9.04 Million USD | -506.757% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 7573.112% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -323.691% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -3909.661% |
| Q BioMed Inc. | 4.06 Million USD | -1251.007% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | -79.522% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -5343.101% |
| Biomind Labs Inc. | 711.4 Thousand USD | -7610.268% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 9.406% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -2643.384% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -328.303% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -15148.673% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -39134.214% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -275991.005% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -2390.984% |
| GB Sciences, Inc. | 1.74 Million USD | -3039.157% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 29944.712% |
| HST Global, Inc. | 96.79 Thousand USD | -56568.354% |
| CSL Limited | 10.52 Billion USD | 99.479% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -26498.68% |
| Halberd Corporation | 144.72 Thousand USD | -37801.203% |
| Enzolytics Inc. | 981.65 Thousand USD | -5487.599% |
| Agentix Corp. | 37.63 Thousand USD | -145660.145% |
| Resverlogix Corp. | 6.45 Million USD | -750.271% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 8249.145% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 102.704% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 216.674% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -675.721% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -1925.057% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 720.493% |
| AVAX Technologies, Inc. | -5.9 Million USD | 1029.173% |
| Zenith Capital Corp. | 10.06 Thousand USD | -544921.86% |
| Genscript Biotech Corporation | -1.06 Billion USD | 105.168% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -27266.389% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -2198.836% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -33242.249% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 299537.712% |
| Kadimastem Ltd | -253.1 Thousand USD | 21771.5% |
| Helix BioMedix, Inc. | -2.57 Million USD | 2234.254% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | -170.522% |
| BioStem Technologies, Inc. | 4.47 Million USD | -1126.54% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -27154.614% |
| LadRx Corporation | -2.03 Million USD | 2793.437% |
| Cell Source, Inc. | 9.23 Million USD | -494.142% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -8535.682% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -8535.682% |
| NovAccess Global Inc. | 2.17 Million USD | -2417.874% |
| Affymax, Inc. | -5.59 Million USD | 1080.007% |
| Itoco Inc. | 228.3 Thousand USD | -23925.317% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -40234.88% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -1006.536% |
| Mobile Lads Corp. | 484.23 Thousand USD | -11227.422% |
| CytoDyn Inc. | 20.26 Million USD | -170.709% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 8477843.431% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 591910.4% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -611.796% |
| SYBLEU INC | 473.71 Thousand USD | -11478.927% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -1130.665% |
| International Stem Cell Corporation | 2.59 Million USD | -2017.799% |
| Bioxytran, Inc. | 1.89 Million USD | -2788.546% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -87783.934% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -2415.063% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -1497.292% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -541.307% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -6999.47% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 4488.08% |
| Neutra Corp. | 52.18 Thousand USD | -105004.72% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 2303.736% |
| PureTech Health plc | -167.19 Million USD | 132.806% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 22496.573% |
| IXICO plc | -4.44 Million USD | 1334.108% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -314.941% |
| CSL Limited | 10.52 Billion USD | 99.479% |
| Cellectis S.A. | -43.81 Million USD | 225.177% |